Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (Biological, Chemical, Physical), By Application (Gene Therapy, Cell Therapy, Vaccines, Research), By Method (Ex-vivo, In-vivo, In-vitro) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format: | Report Code: SR2191DR | Pages: 110

Market Segmentation

  1. Gene Delivery Technologies Market, By Mode  2022-2034 (USD MILLION/ Units)
    1. Biological
    2. Chemical
    3. Physical
  2. Gene Delivery Technologies Market, By Application  2022-2034 (USD MILLION/ Units)
    1. Gene Therapy
    2. Cell Therapy
    3. Vaccines
    4. Research
  3. Gene Delivery Technologies Market, By Method 2022-2034 (USD MILLION/ Units)
    1. Ex-vivo
    2. In-vivo
    3. In-vitro
  4. Regional Gene Delivery Technologies Market
    1. North America
      1. North America Gene Delivery Technologies Market By Mode  2022-2034 (USD MILLION/ Units)
        1. Biological
        2. Chemical
        3. Physical
      2. North America Gene Delivery Technologies Market By Application  2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Cell Therapy
        3. Vaccines
        4. Research
      3. North America Gene Delivery Technologies Market By Method 2022-2034 (USD MILLION/ Units)
        1. Ex-vivo
        2. In-vivo
        3. In-vitro
      4. U.S.
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      5. Canada
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
    2. Europe
      1. Europe Gene Delivery Technologies Market By Mode  2022-2034 (USD MILLION/ Units)
        1. Biological
        2. Chemical
        3. Physical
      2. Europe Gene Delivery Technologies Market By Application  2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Cell Therapy
        3. Vaccines
        4. Research
      3. Europe Gene Delivery Technologies Market By Method 2022-2034 (USD MILLION/ Units)
        1. Ex-vivo
        2. In-vivo
        3. In-vitro
      4. U.K.
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      5. Germany
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      6. France
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      7. Spain
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      8. Italy
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      9. Russia
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      10. Nordic
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      11. Benelux
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      12. Rest of Europe
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
    3. APAC
      1. APAC Gene Delivery Technologies Market By Mode  2022-2034 (USD MILLION/ Units)
        1. Biological
        2. Chemical
        3. Physical
      2. APAC Gene Delivery Technologies Market By Application  2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Cell Therapy
        3. Vaccines
        4. Research
      3. APAC Gene Delivery Technologies Market By Method 2022-2034 (USD MILLION/ Units)
        1. Ex-vivo
        2. In-vivo
        3. In-vitro
      4. China
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      5. Korea
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      6. Japan
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      7. India
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      8. Australia
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      9. Taiwan
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      10. South East Asia
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      11. Rest of Asia-Pacific
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
    4. Middle East and Africa
      1. Middle East and Africa Gene Delivery Technologies Market By Mode  2022-2034 (USD MILLION/ Units)
        1. Biological
        2. Chemical
        3. Physical
      2. Middle East and Africa Gene Delivery Technologies Market By Application  2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Cell Therapy
        3. Vaccines
        4. Research
      3. Middle East and Africa Gene Delivery Technologies Market By Method 2022-2034 (USD MILLION/ Units)
        1. Ex-vivo
        2. In-vivo
        3. In-vitro
      4. UAE
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      5. Turkey
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      6. Saudi Arabia
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      7. South Africa
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      8. Egypt
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      9. Nigeria
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      10. Rest of MEA
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
    5. LATAM
      1. LATAM Gene Delivery Technologies Market By Mode  2022-2034 (USD MILLION/ Units)
        1. Biological
        2. Chemical
        3. Physical
      2. LATAM Gene Delivery Technologies Market By Application  2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Cell Therapy
        3. Vaccines
        4. Research
      3. LATAM Gene Delivery Technologies Market By Method 2022-2034 (USD MILLION/ Units)
        1. Ex-vivo
        2. In-vivo
        3. In-vitro
      4. Brazil
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      5. Mexico
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      6. Argentina
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      7. Chile
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      8. Colombia
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
      9. Rest of LATAM
        1. Biological
        2. Chemical
        3. Physical
        4. Gene Therapy
        5. Cell Therapy
        6. Vaccines
        7. Research
        8. Ex-vivo
        9. In-vivo
        10. In-vitro
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: